Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 295
Filtrar
1.
Nat Commun ; 13(1): 260, 2022 01 11.
Artículo en Inglés | MEDLINE | ID: mdl-35017494

RESUMEN

Advances in peptide and protein therapeutics increased the need for rapid and cost-effective polypeptide prototyping. While in vitro translation systems are well suited for fast and multiplexed polypeptide prototyping, they suffer from misfolding, aggregation and disulfide-bond scrambling of the translated products. Here we propose that efficient folding of in vitro produced disulfide-rich peptides and proteins can be achieved if performed in an aggregation-free and thermodynamically controlled folding environment. To this end, we modify an E. coli-based in vitro translation system to allow co-translational capture of translated products by affinity matrix. This process reduces protein aggregation and enables productive oxidative folding and recycling of misfolded states under thermodynamic control. In this study we show that the developed approach is likely to be generally applicable for prototyping of a wide variety of disulfide-constrained peptides, macrocyclic peptides with non-native bonds and antibody fragments in amounts sufficient for interaction analysis and biological activity assessment.


Asunto(s)
Sistema Libre de Células/efectos de los fármacos , Medicamentos Genéricos/química , Medicamentos Genéricos/farmacología , Péptidos/química , Péptidos/farmacología , Animales , Anticuerpos , Análisis Costo-Beneficio , Interpretación Estadística de Datos , Disulfuros , Drosophila melanogaster , Escherichia coli , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Leishmania , Péptidos/genética , Agregado de Proteínas , Dominios Proteicos , ARN Ribosómico 16S , Biología Sintética , Termodinámica
2.
J Neuroinflammation ; 18(1): 42, 2021 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-33573677

RESUMEN

BACKGROUND: Germinal matrix intraventricular hemorrhage (GM-IVH) is associated with deposition of redox active cell-free hemoglobin (Hb), derived from hemorrhagic cerebrospinal fluid (CSF), in the cerebrum and cerebellum. In a recent study, using a preterm rabbit pup model of IVH, intraventricularly administered haptoglobin (Hp), a cell-free Hb scavenger, partially reversed the damaging effects observed following IVH. Together, this suggests that cell-free Hb is central in the pathophysiology of the injury to the immature brain following GM-IVH. An increased understanding of the causal pathways and metabolites involved in eliciting the damaging response following hemorrhage is essential for the continued development and implementation of neuroprotective treatments of GM-IVH in preterm infant. METHODS: We exposed immature primary rat mixed glial cells to hemorrhagic CSF obtained from preterm human infants with IVH (containing a mixture of Hb-metabolites) or to a range of pure Hb-metabolites, incl. oxidized Hb (mainly metHb with iron in Fe3+), oxyHb (mainly Fe2+), or low equivalents of heme, with or without co-administration with human Hp (a mixture of isotype 2-2/2-1). Following exposure, cellular response, reactive oxygen species (ROS) generation, secretion and expression of pro-inflammatory cytokines and oxidative markers were evaluated. RESULTS: Exposure of the glial cells to hemorrhagic CSF as well as oxidized Hb, but not oxyHb, resulted in a significantly increased rate of ROS production that positively correlated with the rate of production of pro-inflammatory and oxidative markers. Congruently, exposure to oxidized Hb caused a disintegration of the polygonal cytoskeletal structure of the glial cells in addition to upregulation of F-actin proteins in microglial cells. Co-administration of Hp partially reversed the damaging response of hemorrhagic CSF and oxidized Hb. CONCLUSION: Exposure of mixed glial cells to oxidized Hb initiates a pro-inflammatory and oxidative response with cytoskeletal disintegration. Early administration of Hp, aiming to minimize the spontaneous autoxidation of cell-free oxyHb and liberation of heme, may provide a therapeutic benefit in preterm infant with GM-IVH.


Asunto(s)
Líquido Cefalorraquídeo/metabolismo , Hemoglobinas/metabolismo , Mediadores de Inflamación/metabolismo , Neuroglía/metabolismo , Oxígeno/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Animales , Animales Recién Nacidos , Técnicas de Cultivo de Célula , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/metabolismo , Hemorragia Cerebral/líquido cefalorraquídeo , Técnicas de Cocultivo , Relación Dosis-Respuesta a Droga , Hemoglobinas/administración & dosificación , Humanos , Recién Nacido , Neuroglía/efectos de los fármacos , Oxígeno/administración & dosificación , Ratas , Ratas Sprague-Dawley
3.
Assay Drug Dev Technol ; 19(3): 184-190, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33471568

RESUMEN

The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay is one of the most commonly used tests of cell proliferation. Hydralazine has been reported to interfere with the performance of the MTS assay when used on adherent cells. This study aimed to investigate whether hydralazine interferes with the performance of the MTS assay on suspended cells. THP-1 (a monocytic leukemia cell line) cells were cultured in the presence or absence of hydralazine (0, 10, 50, 100, and 500 µM) for 2 or 24 h. Cell numbers were analyzed using the MTS, trypan blue exclusion, or microscopic assays. A modified version of the standard MTS assay was established by centrifuging the cells and replacing the test medium with fresh culture medium immediately before the addition of the MTS reagent. Culture of THP-1 cells with hydralazine at concentrations of 50, 100, and 500 µM for 2 h increased absorbance (p < 0.001) in the standard MTS assay, whereas both the trypan blue exclusion assay and microscopy suggested no change in cell numbers. Culture of THP-1 cells with 100 and 500 µm hydralazine for 24 h increased absorbance (p < 0.05) in the standard MTS assay; however, trypan blue exclusion and microscopy suggested a decrease in cell numbers. In a cell-free system, hydralazine (100 and 500 µM) increased absorbance in a time- and concentration-dependent manner. The modified MTS assay produced results consistent with trypan blue exclusion and microscopy using THP-1 cells. In addition, the modified MTS assay produced reliable results when K562 and Jurkat cells were incubated with hydralazine or ß-mercaptoethanol (ßME). In conclusion, a simple modification of the standard MTS assay overcame the interference of hydralazine and ßME when assessing suspended cells.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Hidralazina/farmacología , Mercaptoetanol/farmacología , Sales de Tetrazolio/farmacología , Tiazoles/farmacología , Sistema Libre de Células/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Células Jurkat/efectos de los fármacos , Microscopía , Células THP-1/efectos de los fármacos
4.
RNA Biol ; 18(11): 1727-1738, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-33427029

RESUMEN

Riboswitches are RNA-based regulatory elements that utilize ligand-induced structural changes in the 5'-untranslated region of mRNA to regulate the expression of associated genes. The majority of synthetic riboswitches have been selected and tested in cell-based systems. Cell-free protein expression systems (CFPS) have several advantages for the development and testing of synthetic riboswitches, including eliminating interactions with complex cellular networks, and the decoupling of transcription and translation processes. To gain a better understanding of the riboswitch regulatory mechanism, to allow for more efficient riboswitch optimization and use for biosensing applications, we studied the performance of a theophylline-responsive synthetic riboswitch coupled with the superfolder green fluorescent protein (sfGFP) reporter gene in E. coli cellular extract and PURE cell-free systems. To monitor the mRNA dynamics, a malachite green aptamer sequence was added to the 3'-untranslated region of sfGFP mRNA. Performance of the theophylline riboswitch was compared with a constitutively expressed sfGFP (control). Transcription dynamics of the riboswitch mRNA was very similar to the transcription of the control mRNA for all theophylline concentrations tested in both E. coli extract and PURE CFPS. However, sfGFP expression in the riboswitch construct was one order of magnitude lower, even at the highest concentration of theophylline. A mathematical model of riboswitch activation governed by the kinetic trapping mechanism was developed. Two factors - a reduced fraction of mRNA in the 'ON' state and a considerably lower translation initiation rate in the riboswitch - contribute to the much lower level of protein expression in the theophylline riboswitch compared to the control construct.


Asunto(s)
Aptámeros de Nucleótidos/química , Sistema Libre de Células/metabolismo , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Proteínas Fluorescentes Verdes/metabolismo , Riboswitch/genética , Biología Sintética/métodos , Teofilina/farmacología , Ingeniería Celular , Sistema Libre de Células/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Proteínas Fluorescentes Verdes/genética , Riboswitch/efectos de los fármacos
5.
J Vis Exp ; (160)2020 06 13.
Artículo en Inglés | MEDLINE | ID: mdl-32597876

RESUMEN

This manuscript describes a protocol to evaluate cancer cell deaths in three dimensional (3D) spheroids of multicellular types of cancer cells using supernatants from Lactobacillus fermentum cell culture, considered as probiotics cultures. The use of 3D cultures to test Lactobacillus cell-free supernatant (LCFS) are a better option than testing in 2D monolayers, especially as L. fermentum can produce anti-cancer effects within the gut. L. fermentum supernatant was identified to possess increased anti-proliferative effects against several colorectal cancer (CRC) cells in 3D culture conditions. Interestingly, these effects were strongly related to the culture model, demonstrating the notable ability of L. fermentum to induce cancer cell death. Stable spheroids were generated from diverse CRCs (colorectal cancer cells) using the protocol presented below. This protocol of generating 3D spheroid is time saving and cost effective. This system was developed to easily investigate the anti-cancer effects of LCFS in multiple types of CRC spheroids. As expected, CRC spheroids treated with LCFS strongly induced cell death during the experiment and expressed specific apoptosis molecular markers as analyzed by qRT-PCR, western blotting, and FACS analysis. Therefore, this method is valuable for exploring cell viability and evaluating the efficacy of anti-cancer drugs.


Asunto(s)
Neoplasias Colorrectales/patología , Probióticos/farmacología , Esferoides Celulares/efectos de los fármacos , Esferoides Celulares/patología , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Sistema Libre de Células/efectos de los fármacos , Humanos
6.
ACS Synth Biol ; 9(4): 856-863, 2020 04 17.
Artículo en Inglés | MEDLINE | ID: mdl-32216368

RESUMEN

Cell-free protein synthesis (CFPS) is a promising platform for protein engineering and synthetic biology. The storage of a CFPS system usually involves lyophilization, during which preventing the conformational damage of involved enzymes is critical to the activity. Herein, we report the protection role of magnesium ions on coupled transcription and translation in a lyophilized cell-free system. Mg2+ prevents the inactivation of the CFPS system from direct colyophilization of enzymes and substrates (nucleotides, and amino acids), and furthermore activates the CFPS system. We propose two-metal-ion regulation of Mg2+: Mg2+ (I) acts as an allosteric role for enzymes to prevent the conformational damage of enzymes from direct binding with substrates during lyophilization which locks up inactive enzyme-substrate complex; Mg2+ (II) consequently binds to enzymes to activate the CFPS system. Our work provides important implications for maximizing protein yields by using a cell-free system in protein engineering and understanding the functions of Mg2+ in biological systems.


Asunto(s)
Regulación Alostérica/efectos de los fármacos , Sistema Libre de Células/efectos de los fármacos , Magnesio/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Aminoácidos/metabolismo , Escherichia coli/citología , Liofilización , Magnesio/química , Nucleótidos/metabolismo , Biología Sintética
7.
Cell Death Dis ; 9(12): 1142, 2018 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-30442925

RESUMEN

Radiation-induced bystander effect (RIBE) is a poorly understood phenomenon wherein non-targeted cells exhibit effects of radiation. We have reported that cell-free chromatin (cfCh) particles that are released from dying cells can integrate into genomes of surrounding healthy cells to induce DNA damage and inflammation. This raised the possibility that RIBE might be induced by cfCh released from irradiated dying cells. When conditioned media from BrdU-labeled irradiated cells were passed through filters of pore size 0.22 µm and incubated with unexposed cells, BrdU-labeled cfCh particles could be seen to readily enter their nuclei to activate H2AX, active Caspase-3, NFκB, and IL-6. A direct relationship was observed with respect to activation of RIBE biomarkers and radiation dose in the range of 0.1-0 Gy. We confirmed by FISH and cytogenetic analysis that cfCh had stably integrated into chromosomes of bystander cells and had led to extensive chromosomal instability. The above RIBE effects could be abrogated when conditioned media were pre-treated with agents that inactivate cfCh, namely, anti-histone antibody complexed nanoparticles (CNPs), DNase I and a novel DNA degrading agent Resveratrol-copper (R-Cu). Lower hemi-body irradiation with γ-rays (0.1-50 Gy) led to activation of H2AX, active Caspase-3, NFκB, and IL-6 in brain cells in a dose-dependent manner. Activation of these RIBE biomarkers could be abrogated by concurrent treatment with CNPs, DNase I and R-Cu indicating that activation of RIBE was not due to radiation scatter to the brain. RIBE activation was seen even when mini-beam radiation was delivered to the umbilical region of mice wherein radiation scatter to brain was negligible and could be abrogated by cfCh inactivating agents. These results indicate that cfCh released from radiation-induced dying cells are activators of RIBE and that it can be prevented by treatment with appropriate cfCh inactivating agents.


Asunto(s)
Cromatina/genética , Inflamación/tratamiento farmacológico , Traumatismos por Radiación/tratamiento farmacológico , Resveratrol/farmacología , Animales , Efecto Espectador/efectos de los fármacos , Efecto Espectador/efectos de la radiación , Caspasa 3/genética , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/efectos de la radiación , Cromatina/efectos de los fármacos , Cromatina/efectos de la radiación , Cobre/farmacología , Medios de Cultivo Condicionados/farmacología , Daño del ADN/efectos de la radiación , Desoxirribonucleasa I/genética , Modelos Animales de Enfermedad , Rayos gamma/efectos adversos , Histonas/genética , Humanos , Inflamación/genética , Inflamación/patología , Interleucina-6/genética , Ratones , FN-kappa B/genética , Traumatismos por Radiación/genética , Traumatismos por Radiación/patología
8.
PLoS One ; 13(7): e0199167, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30044776

RESUMEN

Lactoperoxidase (LPO) is an enzyme found in several exocrine secretions including the airway surface liquid producing antimicrobial substances from mainly halide and pseudohalide substrates. Although the innate immune function of LPO has been documented against several microbes, a detailed characterization of its mechanism of action against influenza viruses is still missing. Our aim was to study the antiviral effect and substrate specificity of LPO to inactivate influenza viruses using a cell-free experimental system. Inactivation of different influenza virus strains was measured in vitro system containing LPO, its substrates, thiocyanate (SCN-) or iodide (I-), and the hydrogen peroxide (H2O2)-producing system, glucose and glucose oxidase (GO). Physiologically relevant concentrations of the components of the LPO/H2O2/(SCN-/I-) antimicrobial system were exposed to twelve different strains of influenza A and B viruses in vitro and viral inactivation was assessed by determining plaque-forming units of non-inactivated viruses using Madin-Darby canine kidney cells (MDCK) cells. Our data show that LPO is capable of inactivating all influenza virus strains tested: H1N1, H1N2 and H3N2 influenza A viruses (IAV) and influenza B viruses (IBV) of both, Yamagata and Victoria lineages. The extent of viral inactivation, however, varied among the strains and was in part dependent on the LPO substrate. Inactivation of H1N1 and H1N2 viruses by LPO showed no substrate preference, whereas H3N2 influenza strains were inactivated significantly more efficiently when iodide, not thiocyanate, was the LPO substrate. Although LPO-mediated inactivation of the influenza B strains tested was strain-dependent, it showed slight preference towards thiocyanate as the substrate. The results presented here show that the LPO/H2O2/(SCN-/I-) cell-free, in vitro experimental system is a functional tool to study the specificity, efficiency and the molecular mechanism of action of influenza inactivation by LPO. These studies tested the hypothesis that influenza strains are all susceptible to the LPO-based antiviral system but exhibit differences in their substrate specificities. We propose that a LPO-based antiviral system is an important contributor to anti-influenza virus defense of the airways.


Asunto(s)
Antivirales/farmacología , Gripe Humana/tratamiento farmacológico , Lactoperoxidasa/química , Orthomyxoviridae/efectos de los fármacos , Animales , Antivirales/química , Sistema Libre de Células/efectos de los fármacos , Perros , Humanos , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Subtipo H1N1 del Virus de la Influenza A/patogenicidad , Subtipo H3N2 del Virus de la Influenza A/efectos de los fármacos , Subtipo H3N2 del Virus de la Influenza A/patogenicidad , Virus de la Influenza B/efectos de los fármacos , Virus de la Influenza B/patogenicidad , Gripe Humana/virología , Compuestos de Yodo/química , Compuestos de Yodo/metabolismo , Compuestos de Yodo/farmacología , Lactoperoxidasa/metabolismo , Células de Riñón Canino Madin Darby , Orthomyxoviridae/patogenicidad , Especificidad por Sustrato , Tiocianatos/química , Tiocianatos/metabolismo , Tiocianatos/farmacología
9.
Breast Cancer Res Treat ; 172(1): 33-43, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30043096

RESUMEN

PURPOSE: Sphingosine kinase 1 (SK1) is a protooncogenic enzyme expressed in many human tumours and is associated with chemoresistance and poor prognosis. It is a potent therapy target and its inhibition chemosensitises solid tumours. Despite recent advances in SK1 inhibitors synthesis and validation, their clinical safety and chemosensitising options are not well described. In this study, we have designed, synthesised and tested a new specific SK1 inhibitor with a low toxicity profile. METHODS: Field template molecular modelling was used for compound design. Lead compounds were tested in cell and mouse cancer models. RESULTS: Field template analysis of three known SK1 inhibitors, SKI-178, 12aa and SK1-I, was performed and compound screening identified six potential new SK1 inhibitors. SK1 activity assays in both cell-free and in vitro settings showed that two compounds were effective SK1 inhibitors. Compound SK-F has potently decreased cancer cell viability in vitro and sensitised mouse breast tumours to docetaxel (DTX) in vivo, without significant whole-body toxicity. CONCLUSION: Through field template screening, we have identified a new SK1 inhibitor, SK-F, which demonstrated antitumour activity in vitro and in vivo without overt toxicity when combined with DTX.


Asunto(s)
Neoplasias de la Mama/tratamiento farmacológico , Docetaxel/farmacología , Inhibidores Enzimáticos/química , Fosfotransferasas (Aceptor de Grupo Alcohol)/antagonistas & inhibidores , Amino Alcoholes/química , Animales , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Sistema Libre de Células/efectos de los fármacos , Resistencia a Antineoplásicos/efectos de los fármacos , Resistencia a Antineoplásicos/genética , Inhibidores Enzimáticos/administración & dosificación , Inhibidores Enzimáticos/síntesis química , Femenino , Humanos , Hidrazinas/química , Ligandos , Ratones , Modelos Moleculares , Fosfotransferasas (Aceptor de Grupo Alcohol)/química , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética , Pirazoles/química , Ensayos Antitumor por Modelo de Xenoinjerto
10.
J Endod ; 44(6): 971-976.e1, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29703618

RESUMEN

INTRODUCTION: The improvement of biomaterials capable of driving the regeneration of the pulp-dentin complex mediated by resident cells is the goal of regenerative dentistry. In the present investigation, a chitosan scaffold (CHSC) that released bioactive concentrations of simvastatin (SIM) was tested, aimed at the development of a cell-free tissue engineering system. METHODS: First, we performed a dose-response assay to select the bioactive dose of SIM capable of inducing an odontoblastic phenotype in dental pulp cells (DPCs); after which we evaluated the synergistic effect of this dosage with the CHSC/DPC construct. SIM at 1.0 µmol/L (CHSC-SIM1.0) and 0.5 µmol/L were incorporated into the CHSC, and cell viability, adhesion, and calcium deposition were evaluated. Finally, we assessed the biomaterials in an artificial pulp chamber/3-dimensional culture model to simulate the cell-free approach in vitro. RESULTS: SIM at 0.1 µmol/L was selected as the bioactive dose. This drug was capable of strongly inducing an odontoblastic phenotype on the DPC/CHSC construct. The incorporation of SIM into CHSC had no deleterious effect on cell viability and adhesion to the scaffold structure. CHSC-SIM1.0 led to significantly higher calcium-rich matrix deposition on scaffold/dentin disc assay compared with the control (CHSC). This biomaterial induced the migration of DPCs from a 3-dimensional culture to its surface as well as stimulated significantly higher expressions of alkaline phosphatase, collagen type 1 alpha 1, dentin matrix acidic phosphoprotein 1, and dentin sialophosphoprotein on 3-dimensional-cultured DPCs than on those in contact with CHSC. CONCLUSIONS: CHSC-SIM1.0 scaffold was capable of increasing the chemotaxis and regenerative potential of DPCs.


Asunto(s)
Sistema Libre de Células/efectos de los fármacos , Quitosano/uso terapéutico , Pulpa Dental/fisiología , Dentina/fisiología , Regeneración/efectos de los fármacos , Simvastatina/uso terapéutico , Ingeniería de Tejidos/métodos , Andamios del Tejido , Sistema Libre de Células/fisiología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Humanos , Masculino , Endodoncia Regenerativa/métodos , Simvastatina/administración & dosificación , Adulto Joven
11.
Toxicol Appl Pharmacol ; 345: 19-25, 2018 04 15.
Artículo en Inglés | MEDLINE | ID: mdl-29499249

RESUMEN

Many diseases and disorders are linked to exposure to endocrine disrupting chemicals (EDCs) that mimic the function of natural estrogen hormones. Here we present a Rapid Adaptable Portable In-vitro Detection biosensor platform (RAPID) for detecting chemicals that interact with the human estrogen receptor ß (hERß). This biosensor consists of an allosteric fusion protein, which is expressed using cell-free protein synthesis technology and is directly assayed by a colorimetric response. The resultant biosensor successfully detected known EDCs of hERß (BPA, E2, and DPN) at similar or better detection range than an analogous cell-based biosensor, but in a fraction of time. We also engineered cell-free protein synthesis reactions with RNAse inhibitors to increase production yields in the presence of human blood and urine. The RAPID biosensor successfully detects EDCs in these human samples in the presence of RNAse inhibitors. Engineered cell-free protein synthesis facilitates the use of protein biosensors in complex sample matrices without cumbersome protein purification.


Asunto(s)
Técnicas Biosensibles/métodos , Sistema Libre de Células/metabolismo , Disruptores Endocrinos/sangre , Disruptores Endocrinos/orina , Biosíntesis de Proteínas/fisiología , Sistema Libre de Células/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Disruptores Endocrinos/farmacología , Receptor beta de Estrógeno/antagonistas & inhibidores , Receptor beta de Estrógeno/metabolismo , Humanos , Biosíntesis de Proteínas/efectos de los fármacos
12.
Arch Physiol Biochem ; 124(2): 171-174, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-28871825

RESUMEN

Ozone autohemotherapy is used in the treatment of some diseases. Carbonic anhydrases (CAs, EC 4.2.1.1) are metalloenzymes and play a role in homeostatic mechanisms. The aim of this study was to investigate the effects of ozone on human red blood cell CA (hCA) enzyme activity. Blood samples were treated with different doses of ozone (10, 20, 30 µg/ml) and the erythrocyte total CA activities were determined. Also, purified hCAI and hCAII isozymes were treated with the same doses of ozone and the enzyme activities were measured. About 30 µg/ml ozone treatment decreased the purified hCAI and hCAII activity and increased the total CA activity compared to the control. Because the implication of CAs on many physiological and biochemical processes is linked to pathologies, it can be suggested that the ozone at a concentration of 30 µg/ml is safely used by autohaemotherapy in a well-designed clinical trial.


Asunto(s)
Inhibidores de Anhidrasa Carbónica/farmacología , Anhidrasas Carbónicas/metabolismo , Eritrocitos/efectos de los fármacos , Oxidantes Fotoquímicos/farmacología , Ozono/farmacología , Anhidrasa Carbónica I/antagonistas & inhibidores , Anhidrasa Carbónica I/aislamiento & purificación , Anhidrasa Carbónica I/metabolismo , Anhidrasa Carbónica II/antagonistas & inhibidores , Anhidrasa Carbónica II/aislamiento & purificación , Anhidrasa Carbónica II/metabolismo , Inhibidores de Anhidrasa Carbónica/efectos adversos , Anhidrasas Carbónicas/química , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/enzimología , Cromatografía de Afinidad , Eritrocitos/enzimología , Humanos , Concentración Osmolar , Oxidantes Fotoquímicos/efectos adversos , Ozono/efectos adversos
13.
Toxicol In Vitro ; 47: 18-25, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29104035

RESUMEN

There is a need to adapt cell bioassays to 384-well and 1536-well formats instead of the traditional 96-well format as high-throughput screening (HTS) demands increase. However, the sensitivity and performance of the bioassay must be re-verified in these higher micro-well plates, and verification of cell health must also be HT (high-throughput). We have adapted two commonly used human breast luciferase transactivation cell bioassays, the recently re-named estrogen agonist/antagonist screening VM7Luc4E2 cell bioassay (previously designated BG1Luc4E2) and the androgen/glucocorticoid screening MDA-kb2 cell bioassay, to 384-well formats for HTS of endocrine-active substances (EASs). This cost-saving adaptation includes a fast, accurate, and easy measurement of protein amount in each well via the fluorescamine assay with which to normalize luciferase activity of cell lysates without requiring any transfer of the cell lysates. Here we demonstrate that by accounting for protein amount in the cell lysates, antagonistic agents can easily be distinguished from cytotoxic agents in the MDA-kb2 and VM7Luc4E2 cell bioassays. Additionally, we demonstrate via the fluorescamine assay improved interpretation of luciferase activity in wells along the edge of the plate (the so-called "edge effect"), thereby increasing usable wells to the entire plate, not just interior wells.


Asunto(s)
Disruptores Endocrinos/toxicidad , Fluorescamina/análisis , Colorantes Fluorescentes/análisis , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Genes Reporteros/efectos de los fármacos , Luciferasas/metabolismo , Activación Transcripcional/efectos de los fármacos , Antineoplásicos/farmacología , Bioensayo , Neoplasias de la Mama/inducido químicamente , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Línea Celular Tumoral , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/metabolismo , Sistema Libre de Células/patología , Femenino , Fluorescamina/química , Colorantes Fluorescentes/química , Ensayos Analíticos de Alto Rendimiento , Antagonistas de Hormonas/farmacología , Humanos , Cinética , Límite de Detección , Luciferasas/genética , Proteínas Recombinantes/metabolismo , Reproducibilidad de los Resultados
14.
Arch Biochem Biophys ; 633: 23-28, 2017 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-28887129

RESUMEN

The alcohol abuse drug disulfiram has also been shown to exhibit potent cell growth inhibitory and anticancer activity. While a number of cellular and animal studies have suggested that disulfiram exhibits its anticancer activity through interaction with the proteasome, direct evidence for inhibition of proteasome activity is lacking. In this study we show that disulfiram potently inhibits the chymotrypsin-like activity of purified human 20S proteasome at low micromolar pharmacological concentrations. The enzyme progress curves displayed characteristics of a slow-binding reaction, similar to that observed for the FDA-approved proteasomal-targeted anticancer drugs bortezomib and carfilzomib. The apparent second order rate constant for reaction with 20s proteasome that was derived from an analysis of the progress curves was about 250-fold smaller than for bortezomib and carfilzomib. The concentration dependence of the enzyme kinetics was consistent with partial noncompetitive inhibition, whereby the putative disulfiram-proteasome adduct retains, partial but decreased enzyme activity. Disulfiram, which is known to have a high affinity for protein thiols, likely reacted with a non-critical cysteine residue, and not at the proteasome substrate binding site.


Asunto(s)
Inhibidores del Acetaldehído Deshidrogenasa/farmacología , Disulfiram/farmacología , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Inhibidores de Proteasoma/farmacología , Antineoplásicos/farmacología , Bortezomib/farmacología , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/enzimología , Humanos , Cinética , Oligopéptidos/farmacología , Complejo de la Endopetidasa Proteasomal/metabolismo , Unión Proteica
15.
Bull Exp Biol Med ; 162(6): 801-807, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28429226

RESUMEN

We studied the effects of some aniline and dioxaborininopyridine derivatives on the rate of oxidative deamination of putrescine and polyamines in a tissue with high mitotic index. These effects were evaluated quantitatively by measuring diamine oxidase and polyamine oxidase activities in a model cell-free test system of regenerating rat liver tissue. Aniline derivatives exhibited mainly antiproliferative effects and promoted oxidative degradation of putrescine, spermidine, and spermine. Dioxaborininopyridine derivatives inhibited this process, thus exhibiting carcinogenic properties.


Asunto(s)
Amina Oxidasa (conteniendo Cobre)/química , Compuestos de Anilina/farmacología , Antineoplásicos/farmacología , Compuestos de Boro/farmacología , Carcinógenos/farmacología , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/química , Piridinas/farmacología , Compuestos de Anilina/síntesis química , Animales , Antineoplásicos/síntesis química , Compuestos de Boro/síntesis química , Carcinógenos/síntesis química , Sistema Libre de Células/química , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/metabolismo , Pruebas de Enzimas , Cinética , Hígado/química , Hígado/metabolismo , Regeneración Hepática , Masculino , Oxidación-Reducción , Putrescina/química , Piridinas/síntesis química , Ratas , Espermidina/química , Espermina/química , Relación Estructura-Actividad , Poliamino Oxidasa
16.
Chem Biodivers ; 14(6)2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28256049

RESUMEN

The need of new anti-inflammatory drugs has led to the search for safer and more potent molecules in distinct sources, such as natural products. This work aimed to explore the anti-inflammatory potential of aqueous extracts from two herbal teas (Annona muricata L. and Jasminum grandiflorum L.) in RAW 264.7 macrophages cells and in cell-free assays. Furthermore, the phenolic composition of both extracts and of their hydrolysates was characterized by HPLC-DAD, in order to establish possible relationships with the biological activity. In a general way, A. muricata displayed a stronger capacity to inhibit nitric oxide (NO) production and the activity of phospholipase A2 (PLA2 ), displaying an IC50 value of 142 µg/ml against this enzyme. A deeper look at phenolic compounds revealed that aglycones had more capacity to inhibit NO and PLA2 than their corresponding glycosides, quercetin being clearly the most potent one (IC50  = 7.47 and 1.36 µm, respectively). In addition, 5-O-caffeoylquinic acid, at 1.56 µm, could also inhibit PLA2 (ca. 35%). Our findings suggest that the consumption of both herbal teas may be a preventive approach to inflammatory disorders.


Asunto(s)
Antiinflamatorios/aislamiento & purificación , Tés de Hierbas , Animales , Annona/química , Antiinflamatorios/farmacología , Sistema Libre de Células/efectos de los fármacos , Jasminum/química , Ratones , Óxido Nítrico/antagonistas & inhibidores , Fenoles/análisis , Fenoles/farmacología , Inhibidores de Fosfolipasa A2 , Extractos Vegetales , Células RAW 264.7
17.
ACS Synth Biol ; 6(3): 535-544, 2017 03 17.
Artículo en Inglés | MEDLINE | ID: mdl-27966891

RESUMEN

Incorporation of unnatural amino acids (uAAs) via codon reassignment is a powerful approach for introducing novel chemical and biological properties to synthesized polypeptides. However, the site-selective incorporation of multiple uAAs into polypeptides is hampered by the limited number of reassignable nonsense codons. This challenge is addressed in the current work by developing Escherichia coli in vitro translation system depleted of specific endogenous tRNAs. The translational activity in this system is dependent on the addition of synthetic tRNAs for the chosen sense codon. This allows site-selective uAA incorporation via addition of tRNAs pre- or cotranslationally charged with uAA. We demonstrate the utility of this system by incorporating the BODIPY fluorophore into the unique AGG codon of the calmodulin(CaM) open reading frame using in vitro precharged BODIPY-tRNACysCCU. The deacylated tRNACysCCU is a poor substrate for Cysteinyl-tRNA synthetase, which ensures low background incorporation of Cys into the chosen codon. Simultaneously, p-azidophenylalanine mediated amber-codon suppression and its post-translational conjugation to tetramethylrhodamine dibenzocyclooctyne (TAMRA-DIBO) were performed on the same polypeptide. This simple and robust approach takes advantage of the compatibility of BODIPY fluorophore with the translational machinery and thus requires only one post-translational derivatization step to introduce two fluorescent labels. Using this approach, we obtained CaM nearly homogeneously labeled with two FRET-forming fluorophores. Single molecule FRET analysis revealed dramatic changes in the conformation of the CaM probe upon its exposure to Ca2+ or a chelating agent. The presented approach is applicable to other sense codons and can be directly transferred to eukaryotic cell-free systems.


Asunto(s)
Aminoácidos/genética , Codón sin Sentido/genética , Biosíntesis de Proteínas/genética , Procesamiento Proteico-Postraduccional/genética , Aminoacil-ARNt Sintetasas/metabolismo , Azidas/farmacología , Calcio/metabolismo , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/metabolismo , Codón de Terminación/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Escherichia coli/metabolismo , Eucariontes/efectos de los fármacos , Eucariontes/genética , Eucariontes/metabolismo , Fenilalanina/análogos & derivados , Fenilalanina/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , ARN de Transferencia/genética
18.
DNA Repair (Amst) ; 43: 24-33, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27235627

RESUMEN

DNA polymerases (pols) are sophisticated protein machines operating in the replication, repair and recombination of genetic material in the complex environment of the cell. DNA pol reactions require at least two divalent metal ions for the phosphodiester bond formation. We explore two understudied roles of metals in pol transactions with emphasis on polα, a crucial enzyme in the initiation of DNA synthesis. We present evidence that the combination of many factors, including the structure of the template/primer, the identity of the metal, the metal turnover in the pol active site, and the influence of the concentration of nucleoside triphosphates, affect DNA pol synthesis. On the poly-dT70 template, the increase of Mg(2+) concentration within the range typically used for pol reactions led to the severe loss of the ability of pol to extend DNA primers and led to a decline in DNA product sizes when extending RNA primers, simulating the effect of "counting" of the number of nucleotides in nascent primers by polα. We suggest that a high Mg(2+) concentration promotes the dynamic formation of unconventional DNA structure(s), thus limiting the apparent processivity of the enzyme. Next, we found that Zn(2+) supported robust polα reactions when the concentration of nucleotides was above the concentration of ions; however, there was only one nucleotide incorporation by the Klenow fragment of DNA pol I. Zn(2+) drastically inhibited polα, but had no effect on Klenow, when Mg(2+) was also present. It is possible that Zn(2+) perturbs metal-mediated transactions in pol active site, for example affecting the step of pyrophosphate removal at the end of each pol cycle necessary for continuation of polymerization.


Asunto(s)
ADN Polimerasa I/metabolismo , Cartilla de ADN/metabolismo , Replicación del ADN/efectos de los fármacos , ADN/biosíntesis , Magnesio/metabolismo , Zinc/metabolismo , Dominio Catalítico , Cationes Bivalentes , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/metabolismo , ADN/genética , ADN Polimerasa I/genética , Cartilla de ADN/genética , Humanos , Magnesio/farmacología , Modelos Moleculares , Conformación de Ácido Nucleico , Nucleótidos/metabolismo , Estructura Secundaria de Proteína , Moldes Genéticos , Zinc/farmacología
19.
J Biosci Bioeng ; 121(5): 591-8, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26472128

RESUMEN

Previous studies have shown that pyrrhocoricin, a proline-rich antimicrobial peptide (PrAMP), killed sensitive species in a dose-dependent manner by specifically binding to DnaK. Here, on the basis of the finding that DnaK-deficient Escherichia coli strains are susceptible to PrAMPs, we used pyrrhocoricin to investigate internal targets other than DnaK. Using conventional antibiotics (bleomycin, streptomycin, and fosfomycin) that have known modes of action, first, we validated the availability of an assay using a cell-free rapid translation system (RTS), which is an in vitro protein synthesis system based on E. coli lysate, for evaluating inhibition of protein synthesis. We found that, similarly to bleomycin and streptomycin, pyrrhocoricin inhibited GFP synthesis in RTS in a concentration-dependent manner. In addition, blockage of transcription and translation steps in RTS was individually estimated using RT-PCR after gene expression to determine mRNA products and using sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine the amounts of GFP expressed from purified mRNA, respectively. The results demonstrated that this inhibition of GFP synthesis by pyrrhocoricin did not occur at the transcription step but rather at the translation step, in a manner similar to that of GFP synthesis by streptomycin, an inhibitor of the translation step by causing misreading of tRNA. These results suggest that RTS is a powerful assay system for determining if antimicrobial peptides inhibit protein synthesis and its transcription and/or translation steps. This is the first study to have shown that pyrrhocoricin inhibited protein synthesis by specifically repressing the translation step.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/química , Péptidos Catiónicos Antimicrobianos/farmacología , Escherichia coli/metabolismo , Proteínas de Insectos/química , Proteínas de Insectos/farmacología , Insectos/química , Prolina/análisis , Biosíntesis de Proteínas/efectos de los fármacos , Animales , Antibacterianos/farmacología , Antiinfecciosos , Bleomicina/farmacología , Sistema Libre de Células/efectos de los fármacos , Escherichia coli/química , Proteínas de Escherichia coli/metabolismo , Proteínas Fluorescentes Verdes/análisis , Proteínas Fluorescentes Verdes/biosíntesis , Proteínas Fluorescentes Verdes/genética , Técnicas In Vitro , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Reproducibilidad de los Resultados , Estreptomicina/farmacología , Transcripción Genética/efectos de los fármacos
20.
J Biol Chem ; 291(7): 3455-67, 2016 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-26668315

RESUMEN

The MAPK-interacting kinases 1 and 2 (MNK1 and MNK2) are activated by extracellular signal-regulated kinases 1 and 2 (ERK1/2) or p38 in response to cellular stress and extracellular stimuli that include growth factors, cytokines, and hormones. Modulation of MNK activity affects translation of mRNAs involved in the cell cycle, cancer progression, and cell survival. However, the mechanism by which MNK selectively affects translation of these mRNAs is not understood. MNK binds eukaryotic translation initiation factor 4G (eIF4G) and phosphorylates the cap-binding protein eIF4E. Using a cell-free translation system from rabbit reticulocytes programmed with mRNAs containing different 5'-ends, we show that an MNK inhibitor, CGP57380, affects translation of only those mRNAs that contain both a cap and a hairpin in the 5'-UTR. Similarly, a C-terminal fragment of human eIF4G-1, eIF4G(1357-1600), which prevents binding of MNK to intact eIF4G, reduces eIF4E phosphorylation and inhibits translation of only capped and hairpin-containing mRNAs. Analysis of proteins bound to m(7)GTP-Sepharose reveals that both CGP and eIF4G(1357-1600) decrease binding of eIF4E to eIF4G. These data suggest that MNK stimulates translation only of mRNAs containing both a cap and 5'-terminal RNA duplex via eIF4E phosphorylation, thereby enhancing the coupled cap-binding and RNA-unwinding activities of eIF4F.


Asunto(s)
Factor 4E Eucariótico de Iniciación/metabolismo , Factor 4G Eucariótico de Iniciación/metabolismo , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Caperuzas de ARN/metabolismo , ARN Mensajero/metabolismo , Sustitución de Aminoácidos , Animales , Sistema Libre de Células/efectos de los fármacos , Sistema Libre de Células/enzimología , Sistema Libre de Células/metabolismo , Factor 4E Eucariótico de Iniciación/química , Factor 4E Eucariótico de Iniciación/genética , Factor 4G Eucariótico de Iniciación/química , Factor 4G Eucariótico de Iniciación/genética , Humanos , Péptidos y Proteínas de Señalización Intracelular/antagonistas & inhibidores , Péptidos y Proteínas de Señalización Intracelular/química , Péptidos y Proteínas de Señalización Intracelular/genética , Secuencias Invertidas Repetidas , Proteínas Mutantes/antagonistas & inhibidores , Proteínas Mutantes/química , Proteínas Mutantes/metabolismo , Fragmentos de Péptidos/antagonistas & inhibidores , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Fosforilación/efectos de los fármacos , Dominios y Motivos de Interacción de Proteínas , Inhibidores de Proteínas Quinasas/farmacología , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/química , Proteínas Serina-Treonina Quinasas/genética , ARN/química , ARN/metabolismo , Caperuzas de ARN/química , Pliegue del ARN/efectos de los fármacos , ARN Mensajero/química , Conejos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Reticulocitos/efectos de los fármacos , Reticulocitos/enzimología , Reticulocitos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...